Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia
To assess the effect of combination antibiotic empirical therapy on 30-day case-fatality rate in neutropenic cancer patients with Pseudomonas aeruginosa (PA) bacteremic pneumonia. This was a multinational, retrospective cohort study of neutropenic onco-hematological patients with PA bloodstream infection (BSI) (2006−2018). The effect of appropriate empirical combination therapy, appropriate monotherapy and inappropriate empirical antibiotic therapy [IEAT] on 30-day case-fatality was assessed only in patients with PA bacteremic pneumonia. Among 1017 PA BSI episodes, pneumonia was the source of BSI in 294 (28.9%). Among those, 52 (17.7%) were caused by a multidrug-resistant (MDR) strain and 68 (23.1%) received IEAT, mainly when the infection was caused by an MDR strain [38/52 (73.1%) vs. 30/242 (12.4%); p < 0.001]. The 30-day case-fatality rate was higher in patients with PA bacteremic pneumonia than in those with PA BSI from other sources (55.1% vs. 31.4%; p < 0.001). IEAT was associated with increased 30-day case-fatality (aHR 1.44 [95%CI 1.01−2.03]; p = 0.042), whereas the use of appropriate combination empirical treatment was independently associated with improved survival (aHR 0.46 [95%CI 0.27−0.78]; p = 0.004). Appropriate empirical monotherapy was not associated with improved overall survival (aHR 1.25 [95%CI 0.76−2.05]; p = 0.39). Combination antibiotic empirical therapy should be administered promptly in febrile neutropenic patients with suspected pneumonia as the source of infection.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Microorganisms - 10(2022), 4 vom: 29. März |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Bloodstream infection |
|---|
| Anmerkungen: |
Date Revised 08.03.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3390/microorganisms10040733 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM339859563 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM339859563 | ||
| 003 | DE-627 | ||
| 005 | 20231226003831.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/microorganisms10040733 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1132.xml |
| 035 | |a (DE-627)NLM339859563 | ||
| 035 | |a (NLM)35456784 | ||
| 035 | |a (PII)733 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Albasanz-Puig, Adaia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 08.03.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a To assess the effect of combination antibiotic empirical therapy on 30-day case-fatality rate in neutropenic cancer patients with Pseudomonas aeruginosa (PA) bacteremic pneumonia. This was a multinational, retrospective cohort study of neutropenic onco-hematological patients with PA bloodstream infection (BSI) (2006−2018). The effect of appropriate empirical combination therapy, appropriate monotherapy and inappropriate empirical antibiotic therapy [IEAT] on 30-day case-fatality was assessed only in patients with PA bacteremic pneumonia. Among 1017 PA BSI episodes, pneumonia was the source of BSI in 294 (28.9%). Among those, 52 (17.7%) were caused by a multidrug-resistant (MDR) strain and 68 (23.1%) received IEAT, mainly when the infection was caused by an MDR strain [38/52 (73.1%) vs. 30/242 (12.4%); p < 0.001]. The 30-day case-fatality rate was higher in patients with PA bacteremic pneumonia than in those with PA BSI from other sources (55.1% vs. 31.4%; p < 0.001). IEAT was associated with increased 30-day case-fatality (aHR 1.44 [95%CI 1.01−2.03]; p = 0.042), whereas the use of appropriate combination empirical treatment was independently associated with improved survival (aHR 0.46 [95%CI 0.27−0.78]; p = 0.004). Appropriate empirical monotherapy was not associated with improved overall survival (aHR 1.25 [95%CI 0.76−2.05]; p = 0.39). Combination antibiotic empirical therapy should be administered promptly in febrile neutropenic patients with suspected pneumonia as the source of infection | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Pseudomonas aeruginosa | |
| 650 | 4 | |a bloodstream infection | |
| 650 | 4 | |a neutropenia | |
| 650 | 4 | |a pneumonia | |
| 650 | 4 | |a septic shock | |
| 700 | 1 | |a Durà-Miralles, Xavier |e verfasserin |4 aut | |
| 700 | 1 | |a Laporte-Amargós, Júlia |e verfasserin |4 aut | |
| 700 | 1 | |a Mussetti, Alberto |e verfasserin |4 aut | |
| 700 | 1 | |a Ruiz-Camps, Isabel |e verfasserin |4 aut | |
| 700 | 1 | |a Puerta-Alcalde, Pedro |e verfasserin |4 aut | |
| 700 | 1 | |a Abdala, Edson |e verfasserin |4 aut | |
| 700 | 1 | |a Oltolini, Chiara |e verfasserin |4 aut | |
| 700 | 1 | |a Akova, Murat |e verfasserin |4 aut | |
| 700 | 1 | |a Montejo, José Miguel |e verfasserin |4 aut | |
| 700 | 1 | |a Mikulska, Malgorzata |e verfasserin |4 aut | |
| 700 | 1 | |a Martín-Dávila, Pilar |e verfasserin |4 aut | |
| 700 | 1 | |a Herrera, Fabián |e verfasserin |4 aut | |
| 700 | 1 | |a Gasch, Oriol |e verfasserin |4 aut | |
| 700 | 1 | |a Drgona, Lubos |e verfasserin |4 aut | |
| 700 | 1 | |a Morales, Hugo Manuel Paz |e verfasserin |4 aut | |
| 700 | 1 | |a Brunel, Anne-Sophie |e verfasserin |4 aut | |
| 700 | 1 | |a García, Estefanía |e verfasserin |4 aut | |
| 700 | 1 | |a Isler, Burcu |e verfasserin |4 aut | |
| 700 | 1 | |a Kern, Winfried V |e verfasserin |4 aut | |
| 700 | 1 | |a Retamar-Gentil, Pilar |e verfasserin |4 aut | |
| 700 | 1 | |a Aguado, José María |e verfasserin |4 aut | |
| 700 | 1 | |a Montero, Milagros |e verfasserin |4 aut | |
| 700 | 1 | |a Kanj, Souha S |e verfasserin |4 aut | |
| 700 | 1 | |a Sipahi, Oguz R |e verfasserin |4 aut | |
| 700 | 1 | |a Calik, Sebnem |e verfasserin |4 aut | |
| 700 | 1 | |a Márquez-Gómez, Ignacio |e verfasserin |4 aut | |
| 700 | 1 | |a Marin, Jorge I |e verfasserin |4 aut | |
| 700 | 1 | |a Gomes, Marisa Z R |e verfasserin |4 aut | |
| 700 | 1 | |a Hemmati, Philipp |e verfasserin |4 aut | |
| 700 | 1 | |a Araos, Rafael |e verfasserin |4 aut | |
| 700 | 1 | |a Peghin, Maddalena |e verfasserin |4 aut | |
| 700 | 1 | |a Del Pozo, José Luis |e verfasserin |4 aut | |
| 700 | 1 | |a Yáñez, Lucrecia |e verfasserin |4 aut | |
| 700 | 1 | |a Tilley, Robert |e verfasserin |4 aut | |
| 700 | 1 | |a Manzur, Adriana |e verfasserin |4 aut | |
| 700 | 1 | |a Novo, Andres |e verfasserin |4 aut | |
| 700 | 1 | |a Pallarès, Natàlia |e verfasserin |4 aut | |
| 700 | 1 | |a Bergas, Alba |e verfasserin |4 aut | |
| 700 | 1 | |a Carratalà, Jordi |e verfasserin |4 aut | |
| 700 | 1 | |a Gudiol, Carlota |e verfasserin |4 aut | |
| 700 | 1 | |a On Behalf Of The Ironic Study Group |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Microorganisms |d 2013 |g 10(2022), 4 vom: 29. März |w (DE-627)NLM247050237 |x 2076-2607 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2022 |g number:4 |g day:29 |g month:03 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/microorganisms10040733 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2022 |e 4 |b 29 |c 03 | ||